1. ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol. Issue 6 (December 2018) Authors: Stamp, Lisa K.; Wallace, Mary; Roberts, Rebecca L.; Frampton, Christopher; Miner, Jeffrey N.; Merriman, Tony R.; Dalbeth, Nicola Journal: Drug metabolism and pharmacokinetics Issue: Volume 33:Issue 6(2018) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An analytical comparison between point-of-care uric acid testing meters. (3rd March 2016) Authors: Paraskos, Jonathan; Berke, Zsofia; Cook, Jason; Miner, Jeffrey N.; Braddock, Martin; Platt, Adam; Hughes, Glen Journal: Expert review of molecular diagnostics Issue: Volume 16:Number 3(2016) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout. (26th June 2016) Authors: Tan, Philip K.; Farrar, Jennifer E.; Gaucher, Eric A.; Miner, Jeffrey N. Journal: Molecular biology and evolution Issue: Volume 33:Number 9(2016:Sep.) Page Start: 2193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With Gout. (7th May 2018) Authors: Kankam, Martin; Hall, Jesse; Gillen, Michael; Yang, Xiaojuan; Shen, Zancong; Lee, Caroline; Liu, Sha; Miner, Jeffrey N.; Walker, Susan; Clauson, Vicki; Wilson, David; Nguyen, Mai Journal: Journal of clinical pharmacology Issue: Volume 58:Number 9(2018) Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗